北京大学学报(医学版) ›› 2018, Vol. 50 ›› Issue (2): 364-367. doi: 10.3969/j.issn.1671-167X.2018.02.027

• 技术方法 • 上一篇    下一篇

固体靶PET核素碘-124的制备、质控及甲状腺分子显像

朱华1,王风1,郭晓轶1,李立强1,段东斑2,刘志博2,杨志1△   

  1. (1.北京大学肿瘤医院暨北京市肿瘤防治研究所核医学科,恶性肿瘤发病机制及转化研究教育部重点实验室,北京100142; 2. 北京大学化学与分子工程学院,北京100871)
  • 出版日期:2018-04-18 发布日期:2018-04-18
  • 通讯作者: 杨志 E-mail:pekyz@163.com
  • 基金资助:
     国家自然科学基金(81401467,81371592)、北京市科技新星项目(Z171100001117020)、北京市卫生局基金(215学科骨干2015-3-072)和北京大学医学工程学交叉学科种子基金项目(BMU20140400)资助

Preparation, quality control and thyroid molecule imaging of solid-target based radionuclide ioine-124

ZHU Hua1, WANG Feng 1, GUO Xiao-yi 1, LI Li-qiang1, DUAN Dong-ban 2, LIU Zhi-bo2, YANG Zhi 1△   

  1. [1. Department of Nuclear Medicine, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing 100142, China; 2. College of Chemistry and Molecular Engineering, Peking University, Beijing 100871, China]
  • Online:2018-04-18 Published:2018-04-18
  • Contact: YANG Zhi E-mail:pekyz@163.com
  • Supported by:
    Supported by the National Natural Science Foundation of China (81401467,81371592 ), Beijing Nova Program (Z171100001117020), Beijing Municipal Commission of Health and Family Planning (215 backbone program 2015-3-072) and Peking University Seed Fund for Medicine-Engineering Interdisciplinary Research Project (BMU20140400)

摘要: 目的:建立利用医用回旋加速器有效生产高放射性活度碘-124(124I)的方法,以期为进一步制备和使用124I提供参考。方法:采用124Te(p, n)124I的质子核反应进行124I的制备,首先通过压片装置将靶材料124TeO2压制在圆形铂金靶上,利用医用回旋加速器轰击靶片6~10 h,然后采用放置12 h的方法除去核不良反应可能产生的杂核素,最后采用碘升华-放射化学分离的方法收集得到124I溶液。静脉注射740 kBq的124I生理盐水溶液至小鼠体内,观察124I的正常生理分布,利用micro-PET/CT可见其在甲状腺有明显富集。结果:通过压片装置能够有效实现200 mg的124TeO2在铂金靶片的压制。固体靶上124Te镀层平滑、均匀、致密,无明显凹坑和裂纹。采用医用回旋加速器以12.0 MeV能量,20.0 μA 质子束,轰击获得370~1 110 MBq的124I,经放射化学分离纯化后可获得370~740 MBq的高放射性活度124I,定容于45 000 Bq/μL 的0.01 mol/L氢氧化钠中,核纯度大于80.0%。经过尾部静脉注射124I生理盐水溶液到小鼠体内后,micro-PET/CT成像发现小鼠体内甲状腺部位具有明显的放射性信号浓聚,另在胃部也有富集,并观察到其从膀胱代谢,该代谢行为符合碘元素在生物体内的代谢规律。结论:通过压片装置成功地进行了124I固体靶片的制备,并利用医用回旋加速器已成功进行了124I的生产,通过碘升华纯化装置,获得370~740 MBq高放射性活度的124I,并实现了模型动物甲状腺的micro-PET/CT分子显像。124I的生产为我国科学研究和临床应用提供一种新的核素奠定了基础。

关键词: 固体靶核素, 碘-124生产, 碲-124靶片, 分子显像

Abstract: Objective:To provide useful information for the further production and application of this novel radio-nuclide for potential clinical application. Methods:124Te(p,n)124I nuclide reaction was used for the 124I production. Firstly, the target material, 124TeO2 (200 mg) and Al2O3 (30 mg) mixture, were compressed into the round platinum based solid target by tablet device. HM-20 medical cyclotron was applied to irradiate the solid target slice for 6-10 h with helium and water cooling. Then, the radiated solid target was placed for 12 h (overnight) to decay the radioactive impurity; finally, 124I was be purified by dry distillation using 1 mL/min nitrogen for about 6 hours and radiochemical separation methods. Micro-PET imaging studies were performed to investigate the metabolism properties and thyroid imaging ability of 124I.After 740 kBq  124I was injected intravenously into the tail vein of the normal mice, the animals were imaged with micro-PET and infused with CT. The micro-PET/CT infusion imaging revealed actual state 124I’s metabolism in the mice. Results: It was been successfully applied for 200 mg 124TeO2 plating by the tablet device on the surface of platinum. It showed smooth, dense surface and without obviously pits and cracks. The enriched 124Te target was irradiated for 6 to 10 hours at about 12.0 MeV with 20 μA current on HM-20 cyclotron. Then 370-1 110 MBq 124I could be produced on the solid target after irradiation and 370-740 MBq high specific activity could be collected afterdry distillation separation and radio-chemical purification.124I product was finally dissolved in 0.01 mol/L NaOH for the future distribution. The gamma spectrum of the produced 124I-solution showed that radionuclide purity was over 80.0%. The micro-PET imaging of 124I in the normal mice exhibited the thyroid and stomach accumulations and kidney metabolism, the bladder could also be clearly visible, which was in accordance with what was previously reported. To the best of our knowledge, it was the first production of 124I report in China. Conclusion: In this study, the preparation of 124TeO2 solid target was successfully carried out by using the tablet device. After irradiation of the 124TeO2 solid target and radio-chemical purification, we successfully produced 370-740 MBq high specific activity 124I by a cyclotron for biomedical application, and microPET imaging of 124I in normal mice exhibited the thyroid accumulations. Also, slight uptake in stomach were also monitored with almost nonuptake in other organs in the micro-PET imaging. The production of 124I is expected to provide a new solid target radionuclide for the scientific research and potential clinical application of our country.

Key words: Solid target radionuclide, Iodine-124 production, Tellurium-124 solid target, Molecular imaging

中图分类号: 

  • R817.4
[1] 韩鸿宾. 脑组织液引流途径与脑内新分区系统的发现[J]. 北京大学学报(医学版), 2019, 51(3): 397-401.
[2] 康磊,霍焱,王荣福,张春丽,闫平,徐小洁. MicroRNA-155靶向的放射性标记探针对乳腺癌小鼠模型的活体显像[J]. 北京大学学报(医学版), 2018, 50(2): 326-330.
[3] 刘萌, 付占立, 邸丽娟, 张建华, 范岩, 张旭初, 王荣福. 利尿肾动态显像在单侧肾盂输尿管连接部狭窄患者的手术或保守治疗中的应用[J]. 北京大学学报(医学版), 2015, 47(4): 638-642.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] 张三. 中文标题测试[J]. 北京大学学报(医学版), 2010, 42(1): 1 -10 .
[2] 赵磊, 王天龙 . 右心室舒张末期容量监测用于肝移植术中容量管理的临床研究[J]. 北京大学学报(医学版), 2009, 41(2): 188 -191 .
[3] 万有, , 韩济生, John E. Pintar. 孤啡肽基因敲除小鼠电针镇痛作用增强[J]. 北京大学学报(医学版), 2009, 41(3): 376 -379 .
[4] 张燕, 韩志慧, 钟延丰, 王盛兰, 李玲玲, 郑丹枫. 骨骼肌活组织检查病理诊断技术的改进及应用[J]. 北京大学学报(医学版), 2009, 41(4): 459 -462 .
[5] 赵奇, 薛世华, 刘志勇, 吴凌云. 同向施压测定自酸蚀与全酸蚀粘接系统粘接强度[J]. 北京大学学报(医学版), 2010, 42(1): 82 -84 .
[6] 林红, 王玉凤, 吴野平. 学校生活技能教育对小学三年级学生行为问题影响的对照研究[J]. 北京大学学报(医学版), 2007, 39(3): 319 -322 .
[7] 丰雷, 程嘉, 王玉凤. 注意缺陷多动障碍儿童的运动协调功能[J]. 北京大学学报(医学版), 2007, 39(3): 333 -336 .
[8] 李岳玲, 钱秋瑾, 王玉凤. 儿童注意缺陷多动障碍成人期预后及其预测因素[J]. 北京大学学报(医学版), 2007, 39(3): 337 -340 .
[9] . 书讯[J]. 北京大学学报(医学版), 2007, 39(3): 225 -328 .
[10] 牟向东, 王广发, 刁小莉, 阙呈立. 肺黏膜相关淋巴组织型边缘区B细胞淋巴瘤一例[J]. 北京大学学报(医学版), 2007, 39(4): 346 -350 .